Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. PureTech Health plc
  6. News
  7. Summary
    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC

(PRTC)
  Report
Delayed London Stock Exchange  -  11:35:19 2023-02-01 am EST
246.50 GBX   -3.14%
07:02aPureTech to Present at the SVB Securities Global Biopharma Conference
BU
01/10Transcript : PureTech Health plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 02:15 PM
CI
01/06PureTech Health Says ADHD Treatment Study Achieves Primary Efficacy Outcome
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Jefferies Reinitiates PureTech Health At Buy

10/13/2022 | 07:35am EST
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about PURETECH HEALTH PLC
07:02aPureTech to Present at the SVB Securities Global Biopharma Conference
BU
01/10Transcript : PureTech Health plc Presents at 41st Annual J.P. Morgan Healthca..
CI
01/06PureTech Health Says ADHD Treatment Study Achieves Primary Efficacy Outcome
MT
01/06PureTech says ADHD treatment shows improved attentional functioning
AN
2022TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact
AN
2022PureTech Provides End of Year Report on Key Progress
BU
2022PureTech Health plc Announces Executive Changes
CI
2022PureTech's LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerabil..
BU
2022PureTech Health plc Announces Topline Results from the Completed, Multi-Part Phase 1 Tr..
CI
2022PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
BU
More news
Analyst Recommendations on PURETECH HEALTH PLC
More recommendations
Financials (USD)
Sales 2022 11,3 M - -
Net income 2022 -88,6 M - -
Net cash 2022 398 M - -
P/E ratio 2022 -7,84x
Yield 2022 -
Capitalization 874 M 874 M -
EV / Sales 2022 42,1x
EV / Sales 2023 49,0x
Nbr of Employees 95
Free-Float 84,4%
Chart PURETECH HEALTH PLC
Duration : Period :
PureTech Health plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 3,13 $
Average target price 7,31 $
Spread / Average Target 133%
EPS Revisions
Managers and Directors
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, COO, CFO, Secretary & Director
Christopher A. Viehbacher Chairman
Joseph B. Bolen Chief Scientific Officer
Julie Krop Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PURETECH HEALTH PLC-4.50%874
MODERNA, INC.-1.98%67 639
IQVIA HOLDINGS INC.11.97%42 611
LONZA GROUP AG14.68%42 044
ALNYLAM PHARMACEUTICALS, INC.-5.15%27 854
SEAGEN INC.8.54%25 897